CHR ORLEANS   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Orleans France (1975)

Organization Overview

First Clinical Trial
2015
NCT02197221
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CH ORLEANS | CHR d'ORLEANS | CHR ORLEANS | CHR Orléans | CHR Orléans, France

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Multiple Myeloma (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Pneumonia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 9